330 related articles for article (PubMed ID: 32615293)
21. Mutation analysis of CCM1, CCM2 and CCM3 genes in a cohort of Italian patients with cerebral cavernous malformation.
D'Angelo R; Marini V; Rinaldi C; Origone P; Dorcaratto A; Avolio M; Goitre L; Forni M; Capra V; Alafaci C; Mareni C; Garrè C; Bramanti P; Sidoti A; Retta SF; Amato A
Brain Pathol; 2011 Mar; 21(2):215-24. PubMed ID: 21029238
[TBL] [Abstract][Full Text] [Related]
22. Molecular diagnosis in cerebral cavernous malformations.
Mondejar R; Lucas M
Neurologia; 2017 Oct; 32(8):540-545. PubMed ID: 26304651
[TBL] [Abstract][Full Text] [Related]
23. Clinical, magnetic resonance imaging, and genetic study of 5 Italian families with cerebral cavernous malformation.
Battistini S; Rocchi R; Cerase A; Citterio A; Tassi L; Lando G; Patrosso MC; Galli R; Brunori P; Sgrò DL; Pitillo G; Lo Russo G; Marocchi A; Penco S
Arch Neurol; 2007 Jun; 64(6):843-8. PubMed ID: 17562932
[TBL] [Abstract][Full Text] [Related]
24. Familial cerebral cavernous malformation presenting with epilepsy caused by mutation in the CCM2 gene: A case report.
Ishii K; Tozaka N; Tsutsumi S; Muroi A; Tamaoka A
Medicine (Baltimore); 2020 Jul; 99(29):e19800. PubMed ID: 32702807
[TBL] [Abstract][Full Text] [Related]
25. Familial cerebral cavernous malformation: Report of a novel KRIT1 mutation in a Portuguese family.
Rosário Marques I; Antunes F; Ferreira N; Grunho M
Seizure; 2017 Dec; 53():72-74. PubMed ID: 29145060
[TBL] [Abstract][Full Text] [Related]
26. A Chinese Family With Cerebral Cavernous Malformation Caused by a Frameshift Mutation of the
Liu W; Liu M; Lu D; Wang J; Cao Z; Liu X; Feng Z; Huang B; Wang X
Front Neurol; 2022; 13():795514. PubMed ID: 35444609
[TBL] [Abstract][Full Text] [Related]
27. Familial Cerebral Cavernous Malformation Syndrome with Concomitant Fourth Ventricular Ependymoma: True Association or Mere Coincidence?
Algattas H; Abou-Al-Shaar H; Mendelson M; Arnold GL; Felker J; Meade J; Greene S
Cancer Genet; 2020 Jun; 244():36-39. PubMed ID: 32434131
[TBL] [Abstract][Full Text] [Related]
28. CCM2 gene polymorphisms in Italian sporadic patients with cerebral cavernous malformation: a case-control study.
D'Angelo R; Scimone C; Rinaldi C; Trimarchi G; Italiano D; Bramanti P; Amato A; Sidoti A
Int J Mol Med; 2012 Jun; 29(6):1113-20. PubMed ID: 22378217
[TBL] [Abstract][Full Text] [Related]
29. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease.
McDonald DA; Shenkar R; Shi C; Stockton RA; Akers AL; Kucherlapati MH; Kucherlapati R; Brainer J; Ginsberg MH; Awad IA; Marchuk DA
Hum Mol Genet; 2011 Jan; 20(2):211-22. PubMed ID: 20940147
[TBL] [Abstract][Full Text] [Related]
30. Structural basis for the disruption of the cerebral cavernous malformations 2 (CCM2) interaction with Krev interaction trapped 1 (KRIT1) by disease-associated mutations.
Fisher OS; Liu W; Zhang R; Stiegler AL; Ghedia S; Weber JL; Boggon TJ
J Biol Chem; 2015 Jan; 290(5):2842-53. PubMed ID: 25525273
[TBL] [Abstract][Full Text] [Related]
31. Genetic Screening of Pediatric Cavernous Malformations.
Merello E; Pavanello M; Consales A; Mascelli S; Raso A; Accogli A; Cama A; Valeria C; De Marco P
J Mol Neurosci; 2016 Oct; 60(2):232-8. PubMed ID: 27561926
[TBL] [Abstract][Full Text] [Related]
32. Molecular Genetic Features of Cerebral Cavernous Malformations (CCM) Patients: An Overall View from Genes to Endothelial Cells.
Riolo G; Ricci C; Battistini S
Cells; 2021 Mar; 10(3):. PubMed ID: 33810005
[TBL] [Abstract][Full Text] [Related]
33. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.
Stockton RA; Shenkar R; Awad IA; Ginsberg MH
J Exp Med; 2010 Apr; 207(4):881-96. PubMed ID: 20308363
[TBL] [Abstract][Full Text] [Related]
34. Relevance of CCM gene polymorphisms for clinical management of sporadic cerebral cavernous malformations.
Rinaldi C; Bramanti P; Scimone C; Donato L; Alafaci C; D'Angelo R; Sidoti A
J Neurol Sci; 2017 Sep; 380():31-37. PubMed ID: 28870584
[TBL] [Abstract][Full Text] [Related]
35. Predictive genetic testing of at-risk relatives requires analysis of all CCM genes after identification of an unclassified CCM1 variant in an individual affected with cerebral cavernous malformations.
Schröder W; Najm J; Spiegler S; Mair M; Viera J; Henn W; Felbor U
Neurosurg Rev; 2014 Jan; 37(1):161-5. PubMed ID: 23722637
[TBL] [Abstract][Full Text] [Related]
36. Cerebral Cavernous Malformation: A Portuguese Family with a Novel CCM1 Mutation.
Marto JP; Gil I; Calado S; Viana-Baptista M
Case Rep Neurol; 2016; 8(3):193-198. PubMed ID: 27790124
[TBL] [Abstract][Full Text] [Related]
37. Genotype-phenotype correlations in cerebral cavernous malformations patients.
Denier C; Labauge P; Bergametti F; Marchelli F; Riant F; Arnoult M; Maciazek J; Vicaut E; Brunereau L; Tournier-Lasserve E
Ann Neurol; 2006 Nov; 60(5):550-556. PubMed ID: 17041941
[TBL] [Abstract][Full Text] [Related]
38. Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus.
Liquori CL; Berg MJ; Squitieri F; Ottenbacher M; Sorlie M; Leedom TP; Cannella M; Maglione V; Ptacek L; Johnson EW; Marchuk DA
Hum Mutat; 2006 Jan; 27(1):118. PubMed ID: 16329096
[TBL] [Abstract][Full Text] [Related]
39. A novel deletion mutation in CCM1 gene (krit1) is detected in a Chinese family with cerebral cavernous malformations.
Ji BH; Qin W; Sun T; Feng GY; He L; Wang YJ
Yi Chuan Xue Bao; 2006 Feb; 33(2):105-10. PubMed ID: 16529293
[TBL] [Abstract][Full Text] [Related]
40. PDCD10 gene mutations in multiple cerebral cavernous malformations.
Cigoli MS; Avemaria F; De Benedetti S; Gesu GP; Accorsi LG; Parmigiani S; Corona MF; Capra V; Mosca A; Giovannini S; Notturno F; Ciccocioppo F; Volpi L; Estienne M; De Michele G; Antenora A; Bilo L; Tavoni A; Zamponi N; Alfei E; Baranello G; Riva D; Penco S
PLoS One; 2014; 9(10):e110438. PubMed ID: 25354366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]